Nadia Altomare

Nadia Altomare

Director/Board Member at
Savran Technologies, Inc.
56 year
Health Technology
Consumer Services
Health Services

Profile

Nadia F.
Altomare
is currently the Director at Savran Technologies, Inc. and Patient Rights Advocate, Inc. She was previously the CEO & Director at Abcodia Ltd., Vice President & General Manager at Revvity, Inc., VP & General Manager-Global DNA Analysis at Thermo Fisher Scientific, Inc., and is set to be the Chief Commercial Officer at Sera Prognostics, Inc. until 2023.
Altomare holds an undergraduate degree from Stony Brook University and an MBA from Northeastern University.

Nadia Altomare active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member -

Former positions of Nadia Altomare

CompaniesPositionEnd
SERA PROGNOSTICS, INC. Corporate Officer/Principal 09/06/2023
Chief Executive Officer 01/05/2017
THERMO FISHER SCIENTIFIC, INC. Corporate Officer/Principal 01/01/2014
REVVITY, INC. Corporate Officer/Principal 01/01/2012
See the detail of Nadia Altomare's experience

Training of Nadia Altomare

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

70

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Nadia Altomare